Sarcopenia/Osteosarcopenia Symptoms and Risk Factors

SARCOPENIA AND OSTEOSARCOPENIA INFOGRAPHIC

  • ~3,500 Scopus papers projected for 2025 since sarcopenia received the ICD-10-CM code M62.84 (2016).

  • Higher risks of falls, fractures, mortality; risk escalates further in osteosarcopenia (sarcopenia + osteoporosis).

  • The Global Leadership Initiative in Sarcopenia (GLIS) is finalising universal diagnostic criteria to harmonise case finding and trial endpoints.

  • Standardised cut-points for muscle mass, strength, function, and physical activity are central to the coming guidelines.

Recommended reading and data sources

Other definitions based on regions:

Read more

The new XLH International Guidelines – Webinar Recording Now Available

https://youtu.be/-xvttQfhm9I The new XLH International Guidelines: sharing patients’ and experts’ perspectives. Recording of the workshop on the new X-Linked Hypophosphataemia (XLH) international guidelines. The sessions look back at the journey so far in XLH and discuss the new guidelines from adult and paediatric viewpoints. Supported by an unrestricted educational grant from Kyowa Kirin.

Read more >

Global Perspectives on Orthopaedic Research: How to Collect & Publish Data

IFMRS/ORS Webinar Series Speakers Grace Drury MA Oxf, MA | Global Health Project Manager, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences at the University of Oxford Billy Thomason Haonga, MD | Specialist Orthopaedic Surgeon – MAMC/Muhimbili Orthopaedic Institute, Associate Professor at the Muhimbili University of Health and Allied Sciences – https://muhas.ac.tz/ — The video

Read more >

The new XLH International Guidelines — patients’ and experts’ perspectives

The new XLH International Guidelines: sharing patients’ and experts’ perspectives.  Supported by an unrestricted educational grant of Kyowa Kirin. Open the registration form » Join IFMRS on Wednesday, 29 October, for a free virtual workshop on the new X-Linked Hypophosphataemia (XLH) international guidelines. Hear from leading experts and the XLH community on diagnosing, evaluating, managing, and

Read more >